Breaking News
0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

India's COVID-19 cases cross 20 million, opposition calls for national lockdown

CoronavirusMay 04, 2021 05:01AM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
2/2 © Reuters. FILE PHOTO: Patient suffering from the coronavirus disease (COVID-19) receives treatment inside the casualty ward at a hospital in New Delhi 2/2

By Rajendra Jadhav and Sumit Khanna

SATARA/AHMEDABAD, India (Reuters) -Indian opposition leader Rahul Gandhi called for a nationwide lockdown as the country's tally of coronavirus infections surged past 20 million on Tuesday, becoming the second nation after the United States to pass the grim milestone.

India's deadly second wave of infections, the world's biggest surge in coronavirus infections, has seen it take just over four months to add 10 million cases, versus more than 10 months for its first 10 million.

Currently, the country has 3.45 million active cases.

On Tuesday, India reported 357,229 new cases over the last 24 hours, while deaths rose 3,449 for a toll of 222,408, health ministry data showed.

Medical experts say actual numbers in India could be five to 10 times higher than those reported.

"The only way to stop the spread of Corona now is a full lockdown... GOI’s inaction is killing many innocent people," Congress party MP Gandhi said on Twitter, referring to the Government of India.

Prime Minister Narendra Modi's government is reluctant to impose a national lockdown due to the economic fall out, yet several states have imposed various social restrictions.

The surge in cases of the highly infectious Indian variant of COVID-19 has swamped the health system, drained supplies of medical oxygen vital for survival for those infected, and seen patients dying in ambulances and carparks outside hospitals.

Rows of funeral pyres in parks and carparks cremate the overflow of corpses.

Modi has been criticized for not moving sooner to limit the latest wave of infections and for letting millions of largely unmasked people attend religious festivals and crowded political rallies during March and April.

"What the recent weeks reveal is that both Centre and states have been woefully unprepared for the second wave," an editorial in the Times of India said on Tuesday.

Offering a glimmer of hope, coronavirus cases in some regions were plateauing, a federal health ministry official said on Monday. Government modelling shows cases could peak by Wednesday this week, a few days earlier than a previous estimate, since the virus has spread faster than expected.

VACCINE SCARCITY

The surge in COVID-19 in India has coincided with a dramatic drop in vaccinations, due to problems with supplies and delivery.

At least three Indian states, including the richest state of Maharashtra which includes Mumbai, continued to report vaccine scarcity, shutting down some of its vaccination centres.

The state on Monday administered 79,491 doses, compared to a record 534,372 a week ago.

In Modi's home state of Gujarat, the three largest cities of Ahmedabad, Surat and Vadodara limited vaccines to the 18-44 age group, officials said.

The eastern state of Odisha also halted vaccination drives in 11 out of its 30 districts, local health officials told Reuters, citing paucity of resources.

"I am tired of standing in a queue. I will try one more time. If I don't get it then, I will give up,” said Anil Rajapure, a 49-year-old farmer in Maharashtra's Satara town, who has failed to get his first vaccine shot after three attempts due to either stocks running out or not arriving.

Public forecasts by India's two current vaccine producers show total monthly output of 70-80 million doses would increase only in two months or more, although the number of people eligible for vaccines has doubled to an estimated 800 million since May 1. Just 9.5% of the population of 1.35 billion has received at least a single dose.

India has invited Pfizer (NYSE:PFE), Johnson & Johnson (NYSE:JNJ) and Moderna (NASDAQ:MRNA) Inc to sell their vaccines to the country but none have applied to do so yet.

Pfizer has told the Indian government that there was no concern over the safety of its COVID-19 vaccine, as the country insists on small local trials for foreign shots despite a record surge in infections and shortage of doses.

International aid continued to arrive in India on Tuesday, with 545 oxygen concentrators from the United States landing, the fifth in a series of consignments carrying medical equipment.

India's COVID-19 cases cross 20 million, opposition calls for national lockdown
 

Related Articles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email